HuGE Literature Finder
Records
1
-
4
| Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer. Cancer 2019 Jun . Weitzel Jeffrey N, Neuhausen Susan L, Adamson Aaron, Tao Shu, Ricker Charité, Maoz Asaf, Rosenblatt Margalit, Nehoray Bita, Sand Sharon, Steele Linda, Unzeitig Gary, Feldman Nancy, Blanco Amie M, Hu Donglei, Huntsman Scott, Castillo Danielle, Haiman Christopher, Slavin Thomas, Ziv El |
| A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes. Cancer 2017 1 123 (10): 1721-1730. Buys Saundra S, Sandbach John F, Gammon Amanda, Patel Gayle, Kidd John, Brown Krystal L, Sharma Lavania, Saam Jennifer, Lancaster Johnathan, Daly Mary |
| DNA methylation inhibitor 5-Aza-2'-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B. Molecular and cellular biology 2007 11 28 (2): 752-71. Palii Stela S, Van Emburgh Beth O, Sankpal Umesh T, Brown Kevin D, Robertson Keith |
| Does tumorigenesis select for or against mutations of the DNA repair-associated genes BRCA2 and MRE11?: considerations from somatic mutations in microsatellite unstable (MSI) gastrointestinal cancers. BMC genetics 2006 1 7 3. van der Heijden Michiel S, Brody Jonathan R, Elghalbzouri-Maghrani Elhaam, Zdzienicka Malgorzata Z, Kern Scott |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 31, 2023
- Content source: